WallStreetZenWallStreetZen

NASDAQ: XOMA
Xoma Corp Stock

Open Broker Account
$19.52-1.54 (-7.31%)
Updated Dec 5, 2022
XOMA Price
$19.52
Fair Value Price
$26.36
Market Cap
$223.52M
52 Week Low
$15.68
52 Week High
$32.09
P/E
21.93x
P/B
1.72x
P/S
5.06x
PEG
N/A
Dividend Yield
N/A
Revenue
$40.49M
Earnings
$18.72M
Gross Margin
100%
Operating Margin
46.45%
Profit Margin
24.2%
Debt to Equity
0.12
Operating Cash Flow
$22M
Beta
1.09
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

XOMA Overview

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how XOMA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

XOMA ($19.52) is undervalued by 25.95% relative to our estimate of its Fair Value price of $26.36 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
XOMA ($19.52) is significantly undervalued by 25.95% relative to our estimate of its Fair Value price of $26.36 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
XOMA is forecast by analysts... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more XOMA due diligence checks available for Premium users.

Be the first to know about important XOMA news, forecast changes, insider trades & much more!

XOMA News

Valuation

XOMA fair value

Fair Value of XOMA stock based on Discounted Cash Flow (DCF)
Price
$19.52
Fair Value
$26.36
Undervalued by
25.95%
XOMA ($19.52) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
XOMA ($19.52) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
XOMA is forecast by analysts... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

XOMA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
21.93x
Industry
14.34x
Market
21.63x
XOMA is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
XOMA is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

XOMA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.72x
Industry
4.96x
XOMA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

XOMA's financial health

Profit margin

Revenue
$451.0k
Net Income
-$4.2M
Profit Margin
-1,229.7%
XOMA's Earnings (EBIT) of $18.81M... subscribe to Premium to read more.
Interest Coverage Financials
XOMA's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$146.1M
Liabilities
$15.8M
Debt to equity
0.12
XOMA's short-term assets ($79.74M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
XOMA's short-term assets ($79.74M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
XOMA's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
XOMA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$3.7M
Investing
$26.0k
Financing
-$1.3M
XOMA's operating cash flow ($21.65M)... subscribe to Premium to read more.
Debt Coverage Financials

XOMA vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
XOMA$223.52M-7.31%21.93x1.72x
MOLN$221.75M-2.01%N/A0.87x
ABSI$221.75M-9.43%-2.76x0.76x
NAUT$219.51M-1.12%-3.59x0.67x
CNCE$228.19M-2.06%-1.47x1.71x

Xoma Stock FAQ

What is Xoma's quote symbol?

NASDAQ: XOMA) Xoma trades on the NASDAQ under the ticker symbol XOMA. Xoma stock quotes can also be displayed as NASDAQ: XOMA.

If you're new to stock investing, here's how to buy Xoma stock.

What is the 52 week high and low for Xoma (NASDAQ: XOMA)?

(NASDAQ: XOMA) Xoma's 52-week high was $32.09, and its 52-week low was $15.68. It is currently -39.16% from its 52-week high and 24.49% from its 52-week low.

How much is Xoma stock worth today?

(NASDAQ: XOMA) Xoma currently has 11,450,823 outstanding shares. With Xoma stock trading at $19.52 per share, the total value of Xoma stock (market capitalization) is $223.52M.

Xoma stock was originally listed at a price of $1,668.90 in Dec 31, 1997. If you had invested in Xoma stock at $1,668.90, your return over the last 24 years would have been -98.83%, for an annualized return of -16.92% (not including any dividends or dividend reinvestments).

How much is Xoma's stock price per share?

(NASDAQ: XOMA) Xoma stock price per share is $19.52 today (as of Dec 5, 2022).

What is Xoma's Market Cap?

(NASDAQ: XOMA) Xoma's market cap is $223.52M, as of Dec 6, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Xoma's market cap is calculated by multiplying XOMA's current stock price of $19.52 by XOMA's total outstanding shares of 11,450,823.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.